SCHEMBL4773536

SCHEMBL4773536

OCC(Cc1ccccc1)Nc1cc(-c2cccnc2)nc(-c2ccccn2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.44
CYP3A4 P08684 4/20 0.43
CLK4 Q9HAZ1 3/20 0.43
CYP2D6 P10635 3/20 0.43
CYP1A2 P05177 2/20 0.43
ALDH1A1 P00352 1/20 0.43
HSD17B10 Q99714 1/20 0.43
HIF1A Q16665 1/20 0.43
ECE1 P42892 1/20 0.43
CYP2C19 P33261 2/20 0.42
USP2 O75604 1/20 0.42
CYP2C9 P11712 2/20 0.41
NPC1 O15118 1/20 0.41
TP53 P04637 1/20 0.41
PKM P14618 1/20 0.41
TSHR P16473 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HDAC8 Q9BY41 2/20 0.41
ROCK2 O75116 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4775017 1.00 CYP2A6 (0.44) CYP2A6CYP3A4CLK4CYP2D6CYP1A2
SCHEMBL4773513 1.00 CYP2A6 (0.44) CYP2A6CYP3A4CLK4CYP2D6CYP1A2
SCHEMBL4774839 0.88 DYRK1A (0.51) CYP2A6CYP3A4CYP1A2CYP2C9NPC1
SCHEMBL4773165 0.85 CYP2A6 (0.39) CYP2A6CYP3A4CLK4CYP2D6CYP1A2
SCHEMBL4773182 0.85 CYP2A6 (0.39) CYP2A6CYP3A4CLK4CYP2D6CYP1A2
SCHEMBL4766379 0.83 CYP2A6 (0.46) CYP2A6CYP3A4CLK4CYP2D6CYP1A2
SCHEMBL4766345 0.83 CYP2A6 (0.46) CYP2A6CYP3A4CLK4CYP2D6CYP1A2
SCHEMBL4766503 0.82 CDK4 (0.47) CLK4ECE1ROCK2PRKACAGSK3A
SCHEMBL4773620 0.82 CDK4 (0.47) CLK4ECE1ROCK2PRKACAGSK3A
SCHEMBL4766487 0.82 CDK4 (0.47) CLK4ECE1ROCK2PRKACAGSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1878733-A1 Pyrimidine derivatives as ALK-5 inhibitors Novartis AG (CH) 2008-01-16 EP disclosed